Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yoke-Eng Chiew
Affiliation
Westmead Hospital
ORCID
Career Start Year
1987
Papers
26
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34697060
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Cancer Epidemiol Biomarkers Prev
2022
35816189
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.
Clin Cancer Res
2022
36456881
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.
Nat Genet
2022
32554541
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Clin Cancer Res
2020
29061645
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.
Clin Cancer Res
2018
35135122
<i>BRAF</i> Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.
JCO Precis Oncol
2018
29367611
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.
Sci Rep
2018
28646021
<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.
Cancer Res
2017
28346442
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nat Genet
2017
26017449
Whole-genome characterization of chemoresistant ovarian cancer.
Nature
2015
26506417
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.
Oncotarget
2015
26503049
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.
Nature
2015
26152742
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Clin Cancer Res
2015
25316818
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.
Clin Cancer Res
2014
21976534
Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
Clin Cancer Res
2011
19193619
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
Clin Cancer Res
2009
18698038
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Clin Cancer Res
2008
18980987
Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
Clin Cancer Res
2008
17344846
Patterns of somatic mutation in human cancer genomes.
Nature
2007
16213010
MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.
Gynecol Oncol
2006
15986428
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
Int J Cancer
2005
11106251
Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Clin Cancer Res
2000
10918187
Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
Int J Cancer
2000
9269899
Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
Cell Growth Differ
1997
1517234
Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines.
J Biol Chem
1992
2825791
Studies on pig liver mevalonate-5-diphosphate decarboxylase.
Biochim Biophys Acta
1987
1 - 26 of 26
Column Actions
Search
Recommended Authors
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year
2004
Number of shared co-authors
36
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
1
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year
2001
Number of shared co-authors
0
Saravut J Weroha
Mayo Clinic
Career Start Year
2001
Number of shared co-authors
23
Steve E Kalloger
University of British Columbia
Career Start Year
2000
Number of shared co-authors
28
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
0
Cecilia Williams
Karolinska Institutet
Career Start Year
1997
Number of shared co-authors
3
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
0
Samuel Aparicio
University of British Columbia
Career Start Year
1993
Number of shared co-authors
29
Paul N Span
Radboud University Medical Center
Career Start Year
1993
Number of shared co-authors
12
Phillip Buckhaults
University of South Carolina
Career Start Year
1993
Number of shared co-authors
0
John M S Bartlett
University of Edinburgh
Career Start Year
1992
Number of shared co-authors
11
Barry R Davies
Oncology R&D
Career Start Year
1992
Number of shared co-authors
5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
65
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
4
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
34
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year
1990
Number of shared co-authors
4
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year
1990
Number of shared co-authors
57
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
5
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
1987
Number of shared co-authors
0
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year
1986
Number of shared co-authors
0
Olli Kallioniemi
Karolinska Institute
Career Start Year
1984
Number of shared co-authors
11
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
9
John A Copland
Mayo Clinic Jacksonville
Career Start Year
1982
Number of shared co-authors
6
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year
1982
Number of shared co-authors
88
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year
1982
Number of shared co-authors
7
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year
1977
Number of shared co-authors
5
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year
1976
Number of shared co-authors
40
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
4
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Anna DeFazio
Westmead Hospital
Co-authored papers
25
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers
15
Paul Harnett
Westmead Clinical School, University of Sydney
Co-authored papers
12
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers
11
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers
10
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Co-authored papers
8
Joshy George
Peter MacCallum Cancer Centre
Co-authored papers
8
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers
7
Alison Brand
Westmead Hospital
Co-authored papers
7
Raghwa Sharma
Westmead Hospital
Co-authored papers
7
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers
6
Stacey J Winham
Mayo Clinic
Co-authored papers
6
David G Huntsman
University of British Columbia
Co-authored papers
6
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers
6
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers
6
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers
6
Sean M Grimmond
The University of Melbourne
Co-authored papers
5
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers
5
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
5
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
5
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers
5
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Co-authored papers
5
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
5
Kathryn Alsop
Peter MacCallum Cancer Centre
Co-authored papers
5
Martin K??bel
University of Calgary
Co-authored papers
5
Ian G Campbell
Co-authored papers
5
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers
5
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers
5
Michael S Anglesio
University of British Columbia
Co-authored papers
5
George Au-Yeung
The University of Melbourne
Co-authored papers
4
1 - 30